Global Influenza Vaccine Market Growth 2023-2028

Report ID: 1164225 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Influenza Vaccine Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Influenza Vaccine by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Influenza Vaccine by Country/Region, 2017, 2022 & 2028
    2.2 Influenza Vaccine Segment by Type
        2.2.1 Trivalent Influenza Vaccine
        2.2.2 Quadrivalent Influenza Vaccine
    2.3 Influenza Vaccine Sales by Type
        2.3.1 Global Influenza Vaccine Sales Market Share by Type (2017-2022)
        2.3.2 Global Influenza Vaccine Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Influenza Vaccine Sale Price by Type (2017-2022)
    2.4 Influenza Vaccine Segment by Application
        2.4.1 6 Months to 3 Years
        2.4.2 > 3 Years
    2.5 Influenza Vaccine Sales by Application
        2.5.1 Global Influenza Vaccine Sale Market Share by Application (2017-2022)
        2.5.2 Global Influenza Vaccine Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Influenza Vaccine Sale Price by Application (2017-2022)
3 Global Influenza Vaccine by Company
    3.1 Global Influenza Vaccine Breakdown Data by Company
        3.1.1 Global Influenza Vaccine Annual Sales by Company (2020-2022)
        3.1.2 Global Influenza Vaccine Sales Market Share by Company (2020-2022)
    3.2 Global Influenza Vaccine Annual Revenue by Company (2020-2022)
        3.2.1 Global Influenza Vaccine Revenue by Company (2020-2022)
        3.2.2 Global Influenza Vaccine Revenue Market Share by Company (2020-2022)
    3.3 Global Influenza Vaccine Sale Price by Company
    3.4 Key Manufacturers Influenza Vaccine Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Influenza Vaccine Product Location Distribution
        3.4.2 Players Influenza Vaccine Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Influenza Vaccine by Geographic Region
    4.1 World Historic Influenza Vaccine Market Size by Geographic Region (2017-2022)
        4.1.1 Global Influenza Vaccine Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Influenza Vaccine Annual Revenue by Geographic Region
    4.2 World Historic Influenza Vaccine Market Size by Country/Region (2017-2022)
        4.2.1 Global Influenza Vaccine Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Influenza Vaccine Annual Revenue by Country/Region
    4.3 Americas Influenza Vaccine Sales Growth
    4.4 APAC Influenza Vaccine Sales Growth
    4.5 Europe Influenza Vaccine Sales Growth
    4.6 Middle East & Africa Influenza Vaccine Sales Growth
5 Americas
    5.1 Americas Influenza Vaccine Sales by Country
        5.1.1 Americas Influenza Vaccine Sales by Country (2017-2022)
        5.1.2 Americas Influenza Vaccine Revenue by Country (2017-2022)
    5.2 Americas Influenza Vaccine Sales by Type
    5.3 Americas Influenza Vaccine Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Influenza Vaccine Sales by Region
        6.1.1 APAC Influenza Vaccine Sales by Region (2017-2022)
        6.1.2 APAC Influenza Vaccine Revenue by Region (2017-2022)
    6.2 APAC Influenza Vaccine Sales by Type
    6.3 APAC Influenza Vaccine Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Influenza Vaccine by Country
        7.1.1 Europe Influenza Vaccine Sales by Country (2017-2022)
        7.1.2 Europe Influenza Vaccine Revenue by Country (2017-2022)
    7.2 Europe Influenza Vaccine Sales by Type
    7.3 Europe Influenza Vaccine Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Influenza Vaccine by Country
        8.1.1 Middle East & Africa Influenza Vaccine Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Influenza Vaccine Revenue by Country (2017-2022)
    8.2 Middle East & Africa Influenza Vaccine Sales by Type
    8.3 Middle East & Africa Influenza Vaccine Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Influenza Vaccine
    10.3 Manufacturing Process Analysis of Influenza Vaccine
    10.4 Industry Chain Structure of Influenza Vaccine
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Influenza Vaccine Distributors
    11.3 Influenza Vaccine Customer
12 World Forecast Review for Influenza Vaccine by Geographic Region
    12.1 Global Influenza Vaccine Market Size Forecast by Region
        12.1.1 Global Influenza Vaccine Forecast by Region (2023-2028)
        12.1.2 Global Influenza Vaccine Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Influenza Vaccine Forecast by Type
    12.7 Global Influenza Vaccine Forecast by Application
13 Key Players Analysis
    13.1 Sanofi
        13.1.1 Sanofi Company Information
        13.1.2 Sanofi Influenza Vaccine Product Offered
        13.1.3 Sanofi Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Sanofi Main Business Overview
        13.1.5 Sanofi Latest Developments
    13.2 CSL
        13.2.1 CSL Company Information
        13.2.2 CSL Influenza Vaccine Product Offered
        13.2.3 CSL Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 CSL Main Business Overview
        13.2.5 CSL Latest Developments
    13.3 GSK
        13.3.1 GSK Company Information
        13.3.2 GSK Influenza Vaccine Product Offered
        13.3.3 GSK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GSK Main Business Overview
        13.3.5 GSK Latest Developments
    13.4 Viatris
        13.4.1 Viatris Company Information
        13.4.2 Viatris Influenza Vaccine Product Offered
        13.4.3 Viatris Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Viatris Main Business Overview
        13.4.5 Viatris Latest Developments
    13.5 AstraZeneca
        13.5.1 AstraZeneca Company Information
        13.5.2 AstraZeneca Influenza Vaccine Product Offered
        13.5.3 AstraZeneca Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 AstraZeneca Main Business Overview
        13.5.5 AstraZeneca Latest Developments
    13.6 Hualan Bio
        13.6.1 Hualan Bio Company Information
        13.6.2 Hualan Bio Influenza Vaccine Product Offered
        13.6.3 Hualan Bio Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Hualan Bio Main Business Overview
        13.6.5 Hualan Bio Latest Developments
    13.7 Changchun Institute of Biological
        13.7.1 Changchun Institute of Biological Company Information
        13.7.2 Changchun Institute of Biological Influenza Vaccine Product Offered
        13.7.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Changchun Institute of Biological Main Business Overview
        13.7.5 Changchun Institute of Biological Latest Developments
    13.8 Sinovac
        13.8.1 Sinovac Company Information
        13.8.2 Sinovac Influenza Vaccine Product Offered
        13.8.3 Sinovac Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Sinovac Main Business Overview
        13.8.5 Sinovac Latest Developments
    13.9 BCHT
        13.9.1 BCHT Company Information
        13.9.2 BCHT Influenza Vaccine Product Offered
        13.9.3 BCHT Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 BCHT Main Business Overview
        13.9.5 BCHT Latest Developments
    13.10 Jiangsu GDK
        13.10.1 Jiangsu GDK Company Information
        13.10.2 Jiangsu GDK Influenza Vaccine Product Offered
        13.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Jiangsu GDK Main Business Overview
        13.10.5 Jiangsu GDK Latest Developments
    13.11 KM Biologics
        13.11.1 KM Biologics Company Information
        13.11.2 KM Biologics Influenza Vaccine Product Offered
        13.11.3 KM Biologics Influenza Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 KM Biologics Main Business Overview
        13.11.5 KM Biologics Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Influenza Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Influenza Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Trivalent Influenza Vaccine
    Table 4. Major Players of Quadrivalent Influenza Vaccine
    Table 5. Global Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 6. Global Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 7. Global Influenza Vaccine Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Influenza Vaccine Revenue Market Share by Type (2017-2022)
    Table 9. Global Influenza Vaccine Sale Price by Type (2017-2022) & (USD/Doses)
    Table 10. Global Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 11. Global Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 12. Global Influenza Vaccine Revenue by Application (2017-2022)
    Table 13. Global Influenza Vaccine Revenue Market Share by Application (2017-2022)
    Table 14. Global Influenza Vaccine Sale Price by Application (2017-2022) & (USD/Doses)
    Table 15. Global Influenza Vaccine Sales by Company (2020-2022) & (M Doses)
    Table 16. Global Influenza Vaccine Sales Market Share by Company (2020-2022)
    Table 17. Global Influenza Vaccine Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Influenza Vaccine Revenue Market Share by Company (2020-2022)
    Table 19. Global Influenza Vaccine Sale Price by Company (2020-2022) & (USD/Doses)
    Table 20. Key Manufacturers Influenza Vaccine Producing Area Distribution and Sales Area
    Table 21. Players Influenza Vaccine Products Offered
    Table 22. Influenza Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Influenza Vaccine Sales by Geographic Region (2017-2022) & (M Doses)
    Table 26. Global Influenza Vaccine Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Influenza Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Influenza Vaccine Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Influenza Vaccine Sales by Country/Region (2017-2022) & (M Doses)
    Table 30. Global Influenza Vaccine Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Influenza Vaccine Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Influenza Vaccine Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 34. Americas Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 35. Americas Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 37. Americas Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 38. Americas Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 39. Americas Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 40. Americas Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 41. APAC Influenza Vaccine Sales by Region (2017-2022) & (M Doses)
    Table 42. APAC Influenza Vaccine Sales Market Share by Region (2017-2022)
    Table 43. APAC Influenza Vaccine Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Influenza Vaccine Revenue Market Share by Region (2017-2022)
    Table 45. APAC Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 46. APAC Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 47. APAC Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 48. APAC Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 49. Europe Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 50. Europe Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 51. Europe Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 53. Europe Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 54. Europe Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 55. Europe Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 56. Europe Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Influenza Vaccine Sales by Country (2017-2022) & (M Doses)
    Table 58. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Influenza Vaccine Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Influenza Vaccine Sales by Type (2017-2022) & (M Doses)
    Table 62. Middle East & Africa Influenza Vaccine Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Influenza Vaccine Sales by Application (2017-2022) & (M Doses)
    Table 64. Middle East & Africa Influenza Vaccine Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Influenza Vaccine
    Table 66. Key Market Challenges & Risks of Influenza Vaccine
    Table 67. Key Industry Trends of Influenza Vaccine
    Table 68. Influenza Vaccine Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Influenza Vaccine Distributors List
    Table 71. Influenza Vaccine Customer List
    Table 72. Global Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
    Table 73. Global Influenza Vaccine Sales Market Forecast by Region
    Table 74. Global Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Influenza Vaccine Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
    Table 77. Americas Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Influenza Vaccine Sales Forecast by Region (2023-2028) & (M Doses)
    Table 79. APAC Influenza Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
    Table 81. Europe Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Influenza Vaccine Sales Forecast by Country (2023-2028) & (M Doses)
    Table 83. Middle East & Africa Influenza Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Influenza Vaccine Sales Forecast by Type (2023-2028) & (M Doses)
    Table 85. Global Influenza Vaccine Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Influenza Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Influenza Vaccine Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Influenza Vaccine Sales Forecast by Application (2023-2028) & (M Doses)
    Table 89. Global Influenza Vaccine Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Influenza Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Influenza Vaccine Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Sanofi Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 93. Sanofi Influenza Vaccine Product Offered
    Table 94. Sanofi Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 95. Sanofi Main Business
    Table 96. Sanofi Latest Developments
    Table 97. CSL Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 98. CSL Influenza Vaccine Product Offered
    Table 99. CSL Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 100. CSL Main Business
    Table 101. CSL Latest Developments
    Table 102. GSK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 103. GSK Influenza Vaccine Product Offered
    Table 104. GSK Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 105. GSK Main Business
    Table 106. GSK Latest Developments
    Table 107. Viatris Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 108. Viatris Influenza Vaccine Product Offered
    Table 109. Viatris Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 110. Viatris Main Business
    Table 111. Viatris Latest Developments
    Table 112. AstraZeneca Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 113. AstraZeneca Influenza Vaccine Product Offered
    Table 114. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 115. AstraZeneca Main Business
    Table 116. AstraZeneca Latest Developments
    Table 117. Hualan Bio Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 118. Hualan Bio Influenza Vaccine Product Offered
    Table 119. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 120. Hualan Bio Main Business
    Table 121. Hualan Bio Latest Developments
    Table 122. Changchun Institute of Biological Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 123. Changchun Institute of Biological Influenza Vaccine Product Offered
    Table 124. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 125. Changchun Institute of Biological Main Business
    Table 126. Changchun Institute of Biological Latest Developments
    Table 127. Sinovac Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 128. Sinovac Influenza Vaccine Product Offered
    Table 129. Sinovac Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 130. Sinovac Main Business
    Table 131. Sinovac Latest Developments
    Table 132. BCHT Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 133. BCHT Influenza Vaccine Product Offered
    Table 134. BCHT Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 135. BCHT Main Business
    Table 136. BCHT Latest Developments
    Table 137. Jiangsu GDK Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 138. Jiangsu GDK Influenza Vaccine Product Offered
    Table 139. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 140. Jiangsu GDK Main Business
    Table 141. Jiangsu GDK Latest Developments
    Table 142. KM Biologics Basic Information, Influenza Vaccine Manufacturing Base, Sales Area and Its Competitors
    Table 143. KM Biologics Influenza Vaccine Product Offered
    Table 144. KM Biologics Influenza Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Doses) and Gross Margin (2020-2022)
    Table 145. KM Biologics Main Business
    Table 146. KM Biologics Latest Developments
List of Figures
    Figure 1. Picture of Influenza Vaccine
    Figure 2. Influenza Vaccine Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Influenza Vaccine Sales Growth Rate 2017-2028 (M Doses)
    Figure 7. Global Influenza Vaccine Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Influenza Vaccine Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Trivalent Influenza Vaccine
    Figure 10. Product Picture of Quadrivalent Influenza Vaccine
    Figure 11. Global Influenza Vaccine Sales Market Share by Type in 2021
    Figure 12. Global Influenza Vaccine Revenue Market Share by Type (2017-2022)
    Figure 13. Influenza Vaccine Consumed in 6 Months to 3 Years
    Figure 14. Global Influenza Vaccine Market: 6 Months to 3 Years (2017-2022) & (M Doses)
    Figure 15. Influenza Vaccine Consumed in > 3 Years
    Figure 16. Global Influenza Vaccine Market: > 3 Years (2017-2022) & (M Doses)
    Figure 17. Global Influenza Vaccine Sales Market Share by Application (2017-2022)
    Figure 18. Global Influenza Vaccine Revenue Market Share by Application in 2021
    Figure 19. Influenza Vaccine Revenue Market by Company in 2021 ($ Million)
    Figure 20. Global Influenza Vaccine Revenue Market Share by Company in 2021
    Figure 21. Global Influenza Vaccine Sales Market Share by Geographic Region (2017-2022)
    Figure 22. Global Influenza Vaccine Revenue Market Share by Geographic Region in 2021
    Figure 23. Global Influenza Vaccine Sales Market Share by Region (2017-2022)
    Figure 24. Global Influenza Vaccine Revenue Market Share by Country/Region in 2021
    Figure 25. Americas Influenza Vaccine Sales 2017-2022 (M Doses)
    Figure 26. Americas Influenza Vaccine Revenue 2017-2022 ($ Millions)
    Figure 27. APAC Influenza Vaccine Sales 2017-2022 (M Doses)
    Figure 28. APAC Influenza Vaccine Revenue 2017-2022 ($ Millions)
    Figure 29. Europe Influenza Vaccine Sales 2017-2022 (M Doses)
    Figure 30. Europe Influenza Vaccine Revenue 2017-2022 ($ Millions)
    Figure 31. Middle East & Africa Influenza Vaccine Sales 2017-2022 (M Doses)
    Figure 32. Middle East & Africa Influenza Vaccine Revenue 2017-2022 ($ Millions)
    Figure 33. Americas Influenza Vaccine Sales Market Share by Country in 2021
    Figure 34. Americas Influenza Vaccine Revenue Market Share by Country in 2021
    Figure 35. United States Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 36. Canada Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 37. Mexico Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Brazil Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 39. APAC Influenza Vaccine Sales Market Share by Region in 2021
    Figure 40. APAC Influenza Vaccine Revenue Market Share by Regions in 2021
    Figure 41. China Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Japan Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 43. South Korea Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Southeast Asia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 45. India Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Australia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Europe Influenza Vaccine Sales Market Share by Country in 2021
    Figure 48. Europe Influenza Vaccine Revenue Market Share by Country in 2021
    Figure 49. Germany Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 50. France Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 51. UK Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Italy Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 53. Russia Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Middle East & Africa Influenza Vaccine Sales Market Share by Country in 2021
    Figure 55. Middle East & Africa Influenza Vaccine Revenue Market Share by Country in 2021
    Figure 56. Egypt Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 57. South Africa Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Israel Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Turkey Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 60. GCC Country Influenza Vaccine Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Manufacturing Cost Structure Analysis of Influenza Vaccine in 2021
    Figure 62. Manufacturing Process Analysis of Influenza Vaccine
    Figure 63. Industry Chain Structure of Influenza Vaccine
    Figure 64. Channels of Distribution
    Figure 65. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Influenza Vaccine Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Influenza Vaccine Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Influenza Vaccine Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports